Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikhail V Blagosklonny

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Aging|December 31, 2010
Why the disposable soma theory cannot explain why women live longer and why we ageMikhail V Blagosklonny
Aging|June 4, 2010
Why men age faster but reproduce longer than women: mTOR and evolutionary perspectivesMikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|October 3, 2006
Aging and immortality: quasi-programmed senescence and its pharmacologic inhibitionMikhail V Blagosklonny
Oncotarget|September 10, 2021
Anti-aging: senolytics or gerostatics (unconventional view)Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|July 16, 2004
Analysis of FDA approved anticancer drugs reveals the future of cancer therapyMikhail V Blagosklonny
Oncoscience|December 6, 2021
No limit to maximal lifespan in humans: how to beat a 122-year-old recordMikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Geroconversion: irreversible step to cellular senescenceMikhail V Blagosklonny
Oncoscience|May 2, 2022
Atlos Labs and the quest for immortality: but can we live longer right now?Mikhail V Blagosklonny
Rejuvenation Research|August 30, 2008
Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cellsMikhail V Blagosklonny
Aging|February 17, 2010
Validation of anti-aging drugs by treating age-related diseasesMikhail V Blagosklonny
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Aging|December 31, 2010
Why the disposable soma theory cannot explain why women live longer and why we ageMikhail V Blagosklonny
Aging|June 4, 2010
Why men age faster but reproduce longer than women: mTOR and evolutionary perspectivesMikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|October 3, 2006
Aging and immortality: quasi-programmed senescence and its pharmacologic inhibitionMikhail V Blagosklonny
Oncotarget|September 10, 2021
Anti-aging: senolytics or gerostatics (unconventional view)Mikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|July 16, 2004
Analysis of FDA approved anticancer drugs reveals the future of cancer therapyMikhail V Blagosklonny
Oncoscience|December 6, 2021
No limit to maximal lifespan in humans: how to beat a 122-year-old recordMikhail V Blagosklonny
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Geroconversion: irreversible step to cellular senescenceMikhail V Blagosklonny
Oncoscience|May 2, 2022
Atlos Labs and the quest for immortality: but can we live longer right now?Mikhail V Blagosklonny
Rejuvenation Research|August 30, 2008
Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cellsMikhail V Blagosklonny
Aging|February 17, 2010
Validation of anti-aging drugs by treating age-related diseasesMikhail V Blagosklonny
Pageof 19